Gene · 100187828
Papers1,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human β-defensin-3 and nuclear factor-kappa B p65 synergistically promote the cell proliferation and invasion of oral squamous cell carcinoma. | Transl Oncol | 2023 | 36403504 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches. | Transl Oncol | 2023 | 36401966 | PubTator, text mining | PubMed |
| Disposable screen-printed electrochemical sensing strips for rapid decentralized measurements of salivary ketone bodies: Towards therapeutic and wellness applications. | Biosens Bioelectron | 2023 | 36379173 | PubTator, text mining | PubMed |
| Performance Evaluation of the DxC 700 AU Chemistry Analyzer in Hemoglobin A1c Measurement | Ann Lab Med | 2023 | 36281510 | PubTator, text mining | PubMed |
| Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system. | Mol Ther | 2023 | 36245127 | PubTator, text mining | PubMed |
| Molecular characterization of a novel homozygous deletion in β-globin cluster causing (δβ)0-Thalassemia among Tunisian family. | Ann Clin Biochem | 2023 | 36214153 | PubTator, text mining | PubMed |
| Development of selective inhibitors of phosphatidylinositol 3-kinase C2α. | Nat Chem Biol | 2023 | 36109648 | PubTator, text mining | PubMed |
| Gene expression profiles of ischemic stroke clots retrieved by mechanical thrombectomy are associated with disease etiology. | J Neurointerv Surg | 2023 | 35750484 | PubTator, text mining | PubMed |
| Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study. | Oral Dis | 2023 | 35377498 | PubTator, text mining | PubMed |
| Impact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review. | Ir J Med Sci | 2023 | 35362846 | PubTator, text mining | PubMed |
| Bimodal EEG-fNIRS in Neuroergonomics. Current Evidence and Prospects for Future Research. | Front Neuroergon | 2022 | 38235461 | PubTator, text mining | PubMed |
| Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem. | Phenomics | 2022 | 36939800 | PubTator, text mining | PubMed |
| Hematological Parameters and Demographic Distribution of Hemoglobinopathies and Various Hemoglobin Variants. | Cureus | 2022 | 36721613 | PubTator, text mining | PubMed |
| Clinical genome editing to treat sickle cell disease-A brief update. | Front Med (Lausanne) | 2022 | 36698803 | PubTator, text mining | PubMed |
| Identification of rare thalassemia variants using third-generation sequencing. | Front Genet | 2022 | 36685902 | PubTator, text mining | PubMed |
| Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. | Pathogens | 2022 | 36678387 | PubTator, text mining | PubMed |
| A systematic review on hydroxyurea therapy for sickle cell disease in India. | Indian J Med Res | 2022 | 36629190 | PubTator, text mining | PubMed |
| Burden of sickle cell disease in tribal students in Maa-Baadi institutions in southern Rajasthan - A pilot study. | Indian J Med Res | 2022 | 36629186 | PubTator, text mining | PubMed |
| Rare Combinational Hemoglobinopathies. | Cureus | 2022 | 36628031 | PubTator, text mining | PubMed |
| Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis. | Front Mol Biosci | 2022 | 36605986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100187828/papers?page=17